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Early endosomesEndosomal entrapment is known to be a major bottleneck to successful cytoplasmic delivery of nucleic acids
(NAs) using cationic liposome–NA nanoparticles (NPs). Quantitativemeasurements of distributions of NPswith-
in early endosomes (EEs) have proven difﬁcult due to the sub-resolution size and short lifetime of wildtype EEs.
In this study we used Rab5–GFP, a member of the large family of GTPases which cycles between the plasma
membrane and early endosomes, to ﬂuorescently label early endosomes. Using ﬂuorescence microscopy and
quantitative image analysis of cells expressing Rab5–GFP, we found that at early time points (t b 1 h), only a
fraction (≈35%) of RGD-tagged NPs (which target cell surface integrins) colocalize with wildtype EEs, indepen-
dent of the NP'smembrane charge density. In comparison, a GTP-hydrolysis deﬁcient mutant, Rab5–Q79L, which
extends the size and lifetime of EEs yielding giant early endosomes (GEEs), enabled us to resolve and localize
individual NPs found within the GEE lumen. Remarkably, nearly all intracellular NPs are found to be trapped
within GEEs implying little or no escape at early time points. The observed small degree of colocalization of
NPs and wildtype Rab5 is consistent with recycling of Rab5–GDP to the plasma membrane and not indicative
ofNPescape fromEEs. Taken together, our results show that endosomal escape of PEGylatednanoparticles occurs
downstream of EEs i.e., from late endosomes/lysosomes. Our studies also suggest that Rab5–Q79L could be used
in a robust imaging assay which allows for direct visualization of NP interactions with the luminal membrane of
early endosomes.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Synthetic nucleic acid carriers – whether lipid-, dendrimer- or
polymer-based – are promising candidates for the treatment of various
diseases [1–14]. Relative to viral vectors, synthetic vectors show low
immunogenic response and are generally considered safer [15–17].
Furthermore, synthetic vector/nucleic acid complexes such as cationic
liposome–DNA (CL–DNA) complexes are not limited by theﬁnite capsid
size of viral vectors and can deliver large genetic constructs, including
entire genes (exons and introns) and regulatory sequences [18]. Surface
functionalization of liposomes and lipid-based delivery systems,typically through PEGylation (PEG; polyethylene-glycol) with PEG-
lipids, is required to achieve extended circulation times in vivo
[19–21]. However, PEGylation of CL–DNA nanoparticles (NPs) typically
reduces their transfection efﬁciency (TE; a measure of exogenous gene
expression) by presenting barriers to cell attachment and endosomal
escape [21–23]. One common approach to improve NP internalization
is to use a targeting or cell-penetrating peptide at the distal end of the
PEG-lipid. An added beneﬁt of targeting vectors is that the selective
delivery of payload to the proper tissue or cell type can reduce side
effects and improve efﬁcacy [24–27]. Although a large library of tissue
or cell targeting peptides is being developed [28,29], relatively little is
known about how targeting peptides alter the endocytosis and intra-
cellular trafﬁcking of drugs or nanoparticles.
To elucidate the uptake and intracellular behavior of RGD-tagged CL–
DNA NPs (RGD: Arginine-Glycine-Aspartic Acid), we used ﬂuorescence
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Rab5–GFP and Rab5–Q79L–GFP, a very slowly hydrolyzing mutant, to
measure colocalization of NPs and early endosomes (EEs) in ﬁxed mam-
malian cells. Rab5, amember of the Rab family of GTPases that coordinate
intracellular vesicle budding, trafﬁcking and fusion [30], plays a dominant
role in the formation and function of early endosomes [30–32]. Fig. 1A
shows a typical cycle ofwildtypeRab5 during the endosomal process. Ini-
tially, Rab5 accumulates at the sites of clathrin-coated pits or
macropinocytic rufﬂes where it recruits the necessary proteins for
endosomal budding from the plasma membrane [33–35]. In the GTP-
bound form, Rab5 interacts with effectors which mediate homotypic fu-
sion of other GTP–Rab5 containing endocytic vesicles [36,37]. Upon GTP
hydrolysis, GDP-bound Rab5 will complex with guanosine nucleotide
disassociation inhibitor (GDI)which facilitates transport back to the plas-
mamembrane [38]. The GDP-bound form of Rab5 cannotmediate fusion
and is considered inactive [36]. EEs gradually lose Rab5 as GTP hydrolysis
continues and they simultaneously accumulate Rab7, signifying themat-
uration of the early endosome into a late endosome [39]. The point mu-
tation Q79L hinders GTP hydrolysis activity of Rab5 (labeled Rab5–
Q79L), which increases the ratio of membrane bound GTP–Rab5 to cyto-
solic GDP–Rab5 [36]. When Rab5 is unable to efﬁciently hydrolyze
GTP, early endosomes continuously fuse and form giant early
endosomes (GEEs) [40]. In contrast to EEs, GEEs are longer lived
and spatially resolvable. Although the mutant Rab5–Q79L alters the
maturation process of early endosomes from what is found in the
wildtype case, our ﬁndings show that Rab5–Q79L is a useful tool
for understanding the intracellular pathway of peptide-tagged
PEGylated CL–DNA NPs.
We prepared PEGylated CL–DNA nanoparticles presenting a
linear RGD peptide (GRGDSP) at the distal end of the PEG2000-lipid
(PEG2K-lipid). The RGD motif is common in extracellular matrix
proteins and speciﬁcally binds to integrins: plasma membrane-bound
receptors which are commonly over-expressed in cancer cells [41,42].
Our CL–DNA nanoparticles consisted of MVL5 (a pentavalent cationic
lipid), a neutral lipid (DOPC), and a PEG2K-lipid with or without RGD
(Fig. 2A). CL–DNA complexes based on MVL5 show remarkably highEE
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Fig. 1. Schematic showing the cycle of wildtype Rab5 and mutant Rab5–Q79L. (A) In the case
macropinocytotic rufﬂes (MPR). Once themacropinosome (MP) or clathrin-coated vesicle (CCV
fusionwith other GTP-bound Rab5-labeled vesicles forming the early endosome (EE). On the su
bound Rab5 complexes with guanosine nucleotide disassociation inhibitor (GDI) and underg
exchange of GDP to GTP which completes the cycle. (B) In the case of Rab5–Q79L, GTP hydro
the wildtype case. First, due to fusion of MPs and CCVs being mediated by GTP-bound Rab5, re
giant early endosomes (GEE) that contain an abundance of Rab5–Q79L on the membrane. Sec
into late endosomes, thus the reduced GTP hydrolysis of Rab5–Q79L delays maturation and extransfection efﬁciency when compared to monovalent lipids (e.g.
DOTAP) [43]. Furthermore,MVL5 has also found applications in gene si-
lencing due to its lower toxicity as well as high transfection in the pres-
ence of serum [44–46]. Currently, a cornucopia of literature exists for
conventional lipoplexes lacking PEG-lipid [8,43–50] butwewant to em-
phasize that our vector is a self-assembled PEGylated CL–DNA nanopar-
ticle. Conventional lipoplexes show a large polydispersity of sizes (from
nanometers to microns) but the use of PEG-lipids leads to spontaneous
formation of equilibrium CL–DNA nanoparticles with a smaller
(≈100 nm) size and narrower size distribution [22,23,51–55].
Furthermore, previous work has shown that the grafted PEG polymer
signiﬁcantly alters the NP's interaction with biological membranes
which affects cellular uptake and endosomal escape [52].We conﬁrmed
that complexes lacking PEG2K-lipid (i.e., composed only of MVL5/DOPC
and plasmid DNA) aggregate in the presence of cell media but the
addition of PEG2K-lipid leads to the formation of sub-200 nm
sterically-stabilized nanoparticles (NPs). We compared the TE of
MVL5/DOPC complexes lacking PEGylation with that of PEGylated
MVL5/DOPC NPs both with and without RGD-tagging. Relative to the
control (no PEGylation), PEGylation reduces TE and RGD-tagging
partially recovers TE. Quantitative particle localization, measured via
ﬂuorescent live-cell imaging, revealed that PEGylated CL–DNA NPs
were internalized more efﬁciently upon RGD-tagging. Both types of
NPs (with and without RGD-tagging) showed perinuclear accumula-
tion, indicating endosomal entrapment and motor-based transport of
endosomes. To further probe the endocytic pathway of RGD-tagged
CL–DNA NPs, we used Rab5–GFP constructs to ﬂuorescently label early
endosomes. We used a semi-automated image processing routine to
count the number of intracellular particles found inside and outside of
early endosomes. Although the TE of RGD-taggedNPs strongly increases
with membrane charge density, their uptake and colocalization with
Rab5-labeled EEs was independent of membrane charge density.
Surprisingly, the fraction of NPs colocalizing with wildtype EEs at early
times points (b1 h) was relatively small. While this observation could
suggest another mechanism of entry or efﬁcient escape from early
endosomes, our experiments using the mutant Rab5–Q79L–GFP showGEE
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of wildtype Rab5, GTP-bound Rab5 is recruited to the lumen side of clathrin pits (CP) or
) has pinched off from the plasmamembrane (PM), GTP-bound Rab5mediates homotypic
rface of the EE, GTPase activating protein (GAP) stimulates hydrolysis of GTP to GDP. GDP-
oes transport to the PM. At the PM, guanine nucleotide exchange factor (GEF) promotes
lysis through GAP is severely reduced, resulting in two major phenotypic changes from
duced GTP hydrolysis increases the number of fusion events, leading to the formation of
ond, loss of Rab5 from the EE through GTP hydrolysis is necessary for maturation of EEs
tends the lifetime of EEs.
AB C
PEGylated Nanoparticle RGD-tagged Nanoparticle
Fig. 2. Size and transfection efﬁciency (TE) ofMVL5-based CL–DNA complexes and NPs. (A) Schematic showing the internal nano-structure and functionalized surface of a PEGylated and
RGD-tagged CL–DNA nanoparticle. (B) Dynamic light scattering shows that CL–DNA complexes lacking PEGylation form micron-sized aggregates when complexed in the cell culture
medium DMEM (blue curve). PEGylation with 10mol% PEG2K-lipid or RGD-PEG2K-lipid induces the formation of sub-200 nm, sterically-stabilized nanoparticles (red and green curves).
(C) MVL5/DOPC complexes show remarkably high TE, outperforming the commercial reagent Lipofectamine® 2000. As the concentration of PEG2K-lipid increases (blue bars), TE
decreases. RGD-tagging of MVL5-based NPs partially recovers TE (red bars) relative to the PEGylated NPs lacking RGD. Low-σM NPs contain 30/60/10 DOTAP/DOPC/RGD-PEG2K-lipid
by mol% and show low TE.
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nearly all intracellular NPs were localized inside EEs or GEEs. This sug-
gests that the lack of colocalization of PEGylated NPs with wildtype
Rab5–GFP is merely a result of the short half-life of wildtype early
endosomes and that endosomal escape occurs later in the endocytic
pathway, for example, at the late endosome/lysosome or recycling
stage.2. Materials and methods
2.1. Materials
DOTAP, DOPC and DOPE-PEG2000 were purchased from Avanti
Polar lipids as chloroform solutions. MVL5was synthesized as described
previously [39]. Theﬂuorescent lipids TRITC-DHPE and Texas Red-DHPE
(Invitrogen, Carlsbad, California) have excitation and emission maxima
of 555/589 nm and 580/615 nm, respectively. The RGD-PEG2K-lipid
contained a GRGDSP sequence covalently bound to the distal end of
PEG2K. It was custom synthesized on solid phase using Fmoc-amino
acids and a lipid-PEG2K acid. The pGL3-control vector coding the lucif-
erase gene (Promega, Fitchburg, Wisconsin) was propagated in
Escherichia coli and puriﬁed using a Qiagen Plasmid Mega Prep Kit. The
GFP–Rab5–Q79L plasmid was a gift from the Weimbs lab (UCSB) and
propagated and puriﬁed as described above for pGL3. For cell imaging
studies, the pGL3 vectorwas labeled using theMirus Bio Label IT Nucleic
Acid Labeling Kit with Cy5 (excitation/emission maximum: 649 nm/
670 nm) according to the manufacturer's protocol. For labeling of
early endosomes, the CellLights Early Endosome-GFP BacMam 2.0
(Life Technologies, Carlsbad, California) reagent was used according to
the manufacturer's protocol.2.2. Liposome preparation
Lipid solutions in 3:1 chloroform/methanol were combined at the
desired molar ratio of lipid in glass vials. The RGD-PEG2K-lipid was
dissolved in a 1:1 solution of deionized water/acetonitrile. For
complexes or nanoparticles containingMVL5, liposomeswere prepared
using MVL5/DOPC/PEG2K-lipid at 50/50–x/x where x is 0, 5 or 10.
DOTAP-based complexes were formed with liposomes composed of
DOTAP/DOPC/PEG2K-lipid at 30/60/10 molar ratio. Liposomes used
in live or ﬁxed cell imaging contained 0.5 wt.% (of total lipid) TRITC-
DHPE-lipid or Texas Red-DHPE-lipid label. After mixing, the lipid
solutions in organic solvent were dried, ﬁrst by a stream of nitrogen
and then in a vacuum for 12 h. The appropriate amount of sterile, high
resistivity (18.2 MΩ cm) water to achieve a ﬁnal concentration of
1 mM lipid was then added to the dried lipid ﬁlms, and the resulting
mixtures were incubated at 37 °C for 16 h to form liposomes. Following
this incubation, the liposome solutions were sonicated using a tip
sonicator to form small unilamellar vesicles. When these unilamellar
vesicles are mixed with DNA, they spontaneously self-assemble into
multilamellar nanoparticles [56].
2.3. Cell culture and transfection
Mouse L-cells (ATCC number: CCL-1) were cultured in Dulbecco's
Modiﬁed Eagle Medium (DMEM) supplemented with 5% fetal bovine
serum (HyClone, Logan, Utah) and 1% penicillin/streptomycin
(Invitrogen, Carlsbad, California). Cells were kept at 37 °C in a humidi-
ﬁed atmosphere containing 5% CO2 and were reseeded every 72 h to
maintain subconﬂuency. For transfection studies, cells were seeded in
24-well plates (2.5 × 105 cells/well) such that conﬂuency at transfection
was 60–80%. CL–DNA complexes were formed by diluting 1 μg of DNA
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each (Invitrogen, Carlsbad, California) and mixing. Complexes were in-
cubated for 20 min at room temperature before addition to cells. Cells
were washed oncewith PBS and then incubatedwith 200 μL of complex
suspension (0.4 μg of DNA per well) for 6 h. After 6 h, the transfection
mediumwas removed, and cells were rinsed oncewith PBS and then in-
cubated in supplemented DMEM for 18 h. Cells were harvested in
150 μL of Passive Lysis Buffer (Promega, Fitchburg, Wisconsin) and sub-
jected to one freeze–thaw cycle. Luciferase expression was measured
using a Perkin-Elmer 1420 Victor3 V multilabel counter following the
assay manufacturer's (Promega, Fitchburg, Wisconsin) instructions. TE
results are normalized to total cellular protein as measured by a Brad-
ford Assay (BioRad, Hercules, California). Data points represent an aver-
age of two measurements with error bars showing the standard
deviation. All experiments were repeated at least two times to ensure
reproducibility.
2.4. Dynamic light scattering
The size of CL–DNA complexes and nanoparticles was measured
using a Malvern Nanosizer ZS. CL–DNA particles were prepared in
light-scattering vials in a similar manner to the transfection experi-
ment; DNA and lipid were diluted in equal volumes before mixing. A
total of 2 μg of DNA and the appropriate amount of liposome dispersion
(to achieve the desired lipid/DNA charge ratio ρ) weremixed in 1mL of
DMEMand incubated at room temperature for 20min. Plots show the z-
average diameter. All data points are the average of two measurements
performed on the same sample. Error bars show the standard deviation.
2.5. Live-cell imaging and particle localization
Live-cell imaging was performed using dual-labeled (see the
Materials section) complexes at ρ= 10. The concentration of CL–DNA
NPs was the same as that used in the transfection assay. Cells were
grown to 60% conﬂuency on poly(L-lysine)-coated coverslips (22 mm)
and maintained at 37 °C using a Harvard Warner ﬂow chamber
(Model #P2 and RC21-B Harvard Apparatus, Holliston, Massachusetts).
Images were taken on a Nikon Diaphot 300 using a Nikon 1.4 NA 60×
Plan Apo DIC objective (Nikon, Tokyo, Japan) and Sensicam QE CCD
(PCO AG, Kelheim, Germany). Brightﬁeld images were captured at a
magniﬁcation of 60× in differential interference contract (DIC) mode.
Fluorescent images are composed of two merged channels where one
channel shows lipid (TRITC-DHPE) and the other DNA (Cy5). Images
were analyzed using a MATLAB (The Mathworks, Natick, MA) routine
that measured the intracellular spatial distribution of ﬂuorescently
labeled DNA. Data points and error bars represent the average and
standard deviation of 10 to 20 representative cells. TheMATLAB routine
ﬁrst locates the cell boundary and nuclear membrane using the DIC
image. Next, all intracellular ﬂuorescent particles are located by ﬁtting
a 2D Gaussian to all ﬂuorescent spots contained within the cell bound-
ary. Finally, the closest distance to the nuclear membrane is measured
and recorded for each intracellular particle. Our MATLAB code uses
scripts inspired by [57].
2.6. Endosome labeling assay and particle colocalization
L-cells were seeded on poly-L-lysine coated coverslips in 6-well
plates such that the conﬂuency was 60–80% 24 h after seeding. For
wildtype Rab5 studies, at 24 h post seeding, 15 μL of Invitrogen's
CellLight Early Endosome-GFP Marker (a viral transduction system)
was added to cells and incubated overnight. For mutant Rab5–Q79L
studies, at 24 h post seeding, 4 μg of Rab5–Q79L–GFP plasmid was
complexed with 10 μL of Lipofectamine 2000 according the
manufacturer's protocol, the cell medium was changed to OptiMEM
and complexes were incubated with cells for 4–6 h. The medium was
then aspirated, the cells were washed with PBS, supplemented DMEMwas added, and the cells were incubated overnight. After overnight
incubation in serum-containing DMEM, cells were further serum
starved for 24 h to synchronize cells and reduce cell-to-cell variability
as well as minimize any lingering effects from the Rab–GFP vectors.
From this point forward, the protocol used for wildtype and mutant
Rab5 is identical.
The appropriate amount of Texas Red-labeled liposome solutionwas
added to a solution of 0.1 μg of Cy5-labeled plasmid such that the ﬁnal
charge ratio was ρ = 10 in a total OptiMEM volume of 50 μL. The
resulting dual-labeled NP solution was incubated at room temperature
for 20 min. Cells were removed from the incubator, washed with PBS
and 2 mL of ice-cold OptiMEM was added to the cells. Dual-labeled
particles were then added and the cells were incubated at 4 °C for 1 h.
In summary, for colocalization studies, a 2 mL solution containing
0.1 μg of Cy5-labeled DNA and appropriate lipid was added to each
well. This cold incubation allows particles to bind to the plasma
membrane while endocytosis is thermally inhibited. After 1 h of cold
incubation cells were transferred to 37 °C and 5% CO2 for either 30 or
60 min, as noted with the presented data. After warm incubation, cells
were washed three times with ice-cold PBS containing 50 U/mL of
heparin to remove extracellular complexes [58]. After heparin washing,
cells were ﬁxedwith 3.7% formaldehyde for 15min,washed three times
using room temperature PBS, and mounted using Invitrogen AntiFade
media containing DAPI. Fixed cells were then imaged using an Olympus
(Tokyo, Japan) DSU equipped with a 100× UPlanSApo objective, a Ha-
mamatsu (Hamamatsu, Japan) ImagEM CCD camera and Metamorph
(Nashville, Tennessee) software. Representative cells were chosen and
imaged at z-steps of 250 nm. Z-stacks of the ﬂuorescent channels
were deconvolved using the ImageJ plugin Iterative Deconvolve 3D.
Image processing consisted of Background subtraction with a 20 pixel
rolling ball radius as well as the smooth ﬁlter which improves image
clarity. Z-stacks were then overlayed and z-projected for analysis. Final-
ly, an automated MATLAB routine was used to measure the number of
colocalized ﬂuorescent signals within each cell. The routine locates all
intracellular particles in each ﬂuorescent channel, yielding a list of
coordinates for each channel e.g.; {(x_red1, y_red1), (x_red2, …)},
{(x_green1, y_green1), …} where the red channel corresponds to
lipid, the green channel to endosomes and the blue channel to DNA. If
the distance between particles in different channelswas below a chosen
threshold (typically 3 pixels, ~ 500 nm) then the particle was identiﬁed
as being either (a) a trapped complex (red, blue, green) or (b) a free
complex (red, blue). Similar colocalization routines have been previous-
ly reported in studies of synthetic vectors [59,60].3. Results
In this study complexes consisting of cationic lipid, neutral lipid, and
PEG2000-lipid with (RGD–PEG2K-lipid) or without (PEG2K-lipid) RGD
at the distal end of PEG and plasmid DNA (Fig. 2A) are referred to as
nanoparticles (NPs) due to their stable, sub-100 nm size. CL–DNA com-
plexes (i.e. lipoplexes) without the PEG-lipid component do not form
NPs as their size increases with time in DMEM or physiological buffer
(see Fig. 2B)[61–63]. In contrast to lipid NPs reported elsewhere in the
literature [64], our CL–DNANPs are simply formed bymixing liposomes
and DNA and allowing the components to assemble into their equilibri-
um structure. In addition to varying the coverage of PEG2K (by varying
the mol% of PEG2K-lipid) we also investigated the effect of membrane
charge density. CL–DNA NPs with high membrane charge density (re-
ferred to as High-σM) were composed of MVL5/DOPC/PEG2K-lipid at
50/50–x/x mol% where x = 0, 5, or 10. Low membrane charge density
CL–DNA NPs (referred to as Low-σM) were composed of DOTAP/
DOPC/PEG2K-lipid at 30/60/10 mol%. When referred to as RGD-
tagged, the PEG2K-lipid presented a GRGDSP-OH peptide at the distal
end of the PEG2K. The charge ratio (ratio of positive lipid charges to
negative DNA charges) ρ was set at 10 for all data shown except for
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3.1. Size and transfection efﬁciency of CL–DNA complexes and PEGylated
nanoparticles
The diameter of MVL5/DOPC complexes with no PEG2K-lipid,
10 mol% PEG2K-lipid and 10 mol% RGD-PEG2K-lipid in cell culture
media (DMEM) was measured using dynamic light scattering
(Fig. 2B). MVL5/DOPC complexes lacking PEGylation form large,
micron-sized aggregates for all ρ N 2 which continue to aggregate for
up to 24 h post complex formation. MVL5/DOPC complexes containing
10 mol% PEG2K-lipid or RGD-PEG2K-lipid form stable sub-200 nm NPs
which are resistant to aggregation at all ρ and for at least 24 h after
formation.
Using a luciferase assay,wemeasured the TE of High-σMMVL5/DOPC
complexes at different PEG2K or RGD surface coverage (Fig. 2C).
MVL5/DOPC complexes without PEGylation showed high TE, even
outperforming the benchmark commercial lipofection reagent
Lipofectamine 2000. PEGylation with 5 or 10mol% PEG2K-lipid reduces
TE by 1 and 2 orders of magnitude, respectively. RGD-tagging of
PEGylated NPs partially recovers TE (to a level in between PEGylated
NPs and bare CL–DNA complexes). Low-σM RGD-tagged NPs composed
of DOTAP/DOPC/RGD-PEG2K-lipid at a molar ratio of 30/60/10 showed
low TE (≈106 RLU/mg protein), nearly two orders of magnitude lower
thanMVL5/DOPCNPs at the sameRGD-PEG2Kgrafting density and only
one order of magnitude higher than the naked DNA control.
3.2. Live cell imaging and particle localization
Live cell imaging using differential interference contrast (DIC, Fig. 3A
and C) and ﬂuorescence microscopy (Fig. 3B and D) allowed direct
observation of binding, uptake and intracellular localization. Quantita-
tive imaging allows us tomeasureNP uptakewhile easily differentiating
between NPs bound to the plasma membrane versus NPs internalizedFig. 3. Live-cell imaging of ﬂuorescently-labeled PEGylated MVL5-based nanoparticles with a
RGD-PEG2K-lipid) at 50/40/10 mol% at ρ= 10) are internalized in live L cells (red — TRITC-DH
DNA). (A, B) DIC and ﬂuorescent images of L cells after 4 h of incubation with PEGylated NPs
RGD-tagged NPs. Relative to NPs lacking RGD (A, B), RGD tagging causes a higher number of NP
(solid arrows) are likely endosomes containingmultiple NPswhich are spatially irresolvable. Th
(E) AMATLAB routine was used to determine the boundary and nuclear location of the cell in (
their distance to the nucleus. (F, G) The results of the localization routine for NPs without and w
average the localization results over 20 cells. Spatial localization shows that while both types o
region, approximately three times asmany RGD-tagged particles are found in cells after 5 h of in
bars are 10 μm.within cells. PEGylated NPs lacking RGD adhere to the plasma
membrane via nonspeciﬁc electrostatic-mediated adhesion, undergo
internalization and accumulate in the perinuclear region. The solid
white arrow marks a large, spatially resolvable ﬂuorescent spot which
we interpret as an endosome containing multiple NPs (Fig. 3B and D).
When the NPs contain RGD-PEG2K-lipid, a larger number of intracellu-
lar particles adhere to cells and undergo internalization (Fig. 3D).
Furthermore, along with large resolvable endosomes containing multi-
ple NPs, small resolution-limited spots are visible (dashed arrows). To
quantify intracellular particle localization we used a semi-automated
particle localization routine (see the Materials and methods: Live cell
imaging and particle localization section) which measures the average
number of ﬂuorescent particles found inside cells at a given distance
to the nuclear membrane (Fig. 3G and H). Fig. 3E displays the method
for the case of the cell imaged in DIC (Fig. 3C) and ﬂuorescent
(Fig. 3D) mode. For both NPs with and without RGD-tagging, particles
accumulate in the perinuclear region. Furthermore, by counting the
total number of distinct ﬂuorescent objects per cell (Fig. 3G, inset) we
conﬁrm quantitatively that RGD-tagged NPs are internalized much
more efﬁciently.
3.3. Fixed-cell imaging with Rab5–GFP and Rab5–Q79L–GFP
L cells expressing wildtype Rab5–GFP were incubated with
ﬂuorescently labeled RGD-tagged CL–DNA NPs and ﬁxed after the indi-
cated time (Fig. 4A–D). To visualize only particles in similar endocytic
stages, we employed a two-step incubation. Brieﬂy, cells were incubat-
ed at 4 °C in the presence of NPs, allowing NPs to settle and bind to the
outside of cells while endocytosis remained thermally inhibited
(Fig. S1). After 1 h of incubation with NPs at 4 °C, cells were incubated
at 37 °C for the designated time (30 or 60 min) and extracellular NPs
were removed via cold heparin washing. Intensity proﬁles (Fig. 4E and
F) of intracellular sections show a variety of colocalized signals, e.g.:
NPs inside early endosomes (EEs) (Fig. 4C (ii, iii) and Fig. 2D (v)), NPs
lacking Rab5–GFP colocalization (Fig. 4C (i) and Fig. 4D (vi)), and EEsnd without RGD-tagging. NPs containing multivalent lipid (MVL5/DOPC/(PEG2K-lipid or
PE (lipid), green — Cy5 (DNA), yellow — nanoparticle composed of complexed lipid and
which lack RGD. (C, D) DIC and ﬂuorescent images of L-cells after 4 h of incubation with
s to bind to the plasmamembrane aswell as internalize. Large, bright ﬂuorescent particles
e dashed arrow points to a tiny resolution-limited spot which is believed to be a single NP.
C). Using (D), the routine locates all intracellular particles (red spots in (E)) and measures
ith RGD, respectively. By deﬁning the nuclear membrane as a zero point reference, we can
f MVL5 NPs (with and without RGD-tagging) are uptaken and trafﬁcked to the perinuclear
cubation (a standard incubation time for a TE assay). Inset shows total NPs per cell. All scale
Fig. 4.CL–DNANPs colocalizewith Rab5–GFP-labeled endosomes. (A, B) Fluorescentmicrographs and cell outlines ofwildtype Rab5–GFP-expressing L-cells that have been incubatedwith
ﬂuorescent RGD tagged NPs. The three overlayed channels represent lipid (red), DNA (blue) and Rab5–GFP (green). In (A) Low-σM refers to NPs with DOTAP/PC/RGD-PEG2K-lipid at a
molar ratio of 30/60/10. The cells in (B)were incubatedwith High-σMNPs composed ofMVL5/PC/RGD-PEG2K-lipid at amolar ratio of 50/45/5. (C, D) Highmagniﬁcation of boxed regions
from A and B shows intracellular complexes with (ii, iii, v) and without (i, vi) Rab5 colocalization. (E, F) Intensity proﬁles (dashed lines in C, D) showing signals from all three ﬂuorescent
channels. Early endosomes lacking NPs are also observed (iv). (G, H) Quantitative colocalization shows a statistically signiﬁcant difference in the number of NPs foundwith (+) andwith-
out (−) Rab5–GFP at 30 and 60 min respectively. Although an increase in the number of NPs lacking colocalization with Rab5–GFP is observed from 30 to 60 min, the number of intra-
cellular NPs colocalized with Rab5–GFP does not signiﬁcantly change. All scale bars are 10 μm. Student t-test for colocalization * P b 0.025, ** P b 0.001.
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of intracellular NPs colocalize with Rab5-labeled EE, we used a semi-
automated MATLAB routine which measured the number of intracellu-
lar particles found inside (GFP–Rab5(+)) and outside (GFP–Rab5(−))
of early endosomes (see theMaterials andmethods: Endosome labeling
and particle colocalization section). Fig. 4G and H shows the results of
the NP-EE colocalization routine at 30 and 60 min. The total number
(NTotal = NGFP(+) + NGFP(−)) of intracellular NPs increases with time
and is effectively the same for both membrane charge densities.
Furthermore, a statistically signiﬁcant larger number of NPs are found
outside of EEs at both time points. Although the number of Low-σM
NPs inside EEs slightly increases from 30 to 60 min, the number of
High-σM NPs colocalized with Rab5 slightly decreases with time. We
found that for both High- and Low-σM NPs, the number of particles
lacking Rab5 colocalization signiﬁcantly increases from 30 to 60 min.
Fig. 5A–F contains micrographs and corresponding cropped regions
of cells expressing mutant Rab5–Q79L–GFP that have been incubatedwith High-σM NPs that lack RGD–PEG2K-lipid (Fig. 5A and B) as well
as High- and Low-σM NPs with RGD–PEG2K-lipid (Fig. 5C and D and
Fig. 5E and F respectively). All cells shown were ﬁxed after 1 h of
incubation at 4 °C followed by 1h of incubation at 37 °C. Cells expressing
Rab5–Q79L show giant (N3 μm) early endosomes (GEEs) as well as a
few EEs with similar ﬂuorescence intensity to those observed with
wildtype Rab5 (dashed arrows in Fig. 5E and F, see Fig. S2 for
micrographs and cropped regions without markings). GEEs show non-
uniform GFP ﬂuorescence around their perimeter due to regions of the
membrane rich in Rab5–GFP (red arrows in Fig. 5D, E and F and Fig. 5F
(xi)) suggesting recent fusion of EEswithGEEs. Furthermore, the yellow
arrow and (ii) in Fig. 5D highlight examples where EEs containing a NP
are undergoing fusion with a GEE. Visual inspection shows that in the
case of NPs lacking the RGD motif, we see fewer NPs colocalized with
GEEs (Fig. 5D (i, ii, iii)) relative to those that are RGD-tagged (see
numerous NPs inmagniﬁed images Fig. 5E and F). The cationic liposome
uptake observed in the case of NPs lacking RGD (Fig. 5D (iv)) arises
Fig. 5.Colocalization of CL–DNANPs and giant early endosomes (GEEs). Rab5–Q79L inhibits endosomematuration, showing large (N5 μm) endosomeswith spatially resolvableNPs. Near-
ly all intracellular CL–DNA particles are found within Rab5–Q79L–GFP labeled endosomes (red — TRITC (lipid), green — GFP (endosomes), blue — Cy5 (DNA)). (A, B, C) Fluorescent mi-
crographs and cell boundaries (white outlines) of L-cells after 1 h of incubation with (A) PEGylated High-σM NPs (MVL5/DOPC/PEG2K-lipid at a molar ratio of 50/40/10), (B) RGD-tagged
High-σMNPs (MVL5/DOPC/RGD-PEG2K-lipid at amolar ratio 50/45/5) and (C) RGD-tagged Low-σMNPs (DOTAP/DOPC/RGD-PEG2K-lipid at amolar ratio of 30/60/10). (D, E, F)Highmag-
niﬁcation of boxed regions in A, B, and C. (1–5) Intensity proﬁles of labeled scans from highmagniﬁcation regions. Intensity proﬁles 1 and 2 showNPs (i, ii, iii) and liposomes (iv) found in
EEs and GEEs. Intensity proﬁle 3 shows clear evidence of individually resolvable NPs (v, vi, vii, viii) inside the lumen of the GEE. Intensity proﬁle 4 shows two dim NPs (ix, x) inside a GEE.
Intensity proﬁle 5 shows GFP-rich region of the GEEmembrane (xi) and a cationic liposomewithin an EE (xii). The yellow arrow in (D) points to an EE containing a NP fusing with a GEE.
Red arrows in (D, E, F) show GFP-rich regions of the GEE membrane. Dashed arrows in (E, F) show smaller EEs similar to what is observed with wildtype Rab5. Solid white arrows in
(E) point to clear examples of NPs adhering to the GEE membrane. Scale bars in (A, B, C) and (D, E, F) are 10 μm and 5 μm respectively.
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mechanism of cellular adhesion and uptake where cationic liposomes,
which coexist with NPs for ρ N 1 [62,63], are more cationic compared
to NPs containing charge neutralizing DNA. Signiﬁcantly, the creation
of GEEs in cells expressing Rab5–Q79L has allowed us to spatially
resolve individual RGD-tagged NPs within GEEs (Fig. 3E (v, vi, vii, viii)
and Fig. 5F (ix and x) and corresponding intensity proﬁles). This NPresolvability has led to images which strongly hint at RGD-tagged NPs
adhering to GEE membranes in the case of High-σM (Fig. 5E (v) and
white arrows). Similar to what was observed with NPs lacking RGD,
we also ﬁnd examples of cationic liposomes inside EEs (Fig. 5F (xii)).
Finally, overall inspection of all images conﬁrms that nearly all intracel-
lular NPs, regardless of σM or RGD-tagging, are found within GFP-
labeled GEEs.
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Although PEGylation of lipid-based NPs signiﬁcantly improves
circulation times in vivo, numerous studies have found that PEGylated
NPs suffer from reduced cellular uptake and inefﬁcient endosomal
escape [23,52]. RGD-tagging of PEGylated NPs improves cellular uptake,
but when comparing High- and Low-σM RGD-tagged NPs which
differed in TE by nearly 2 orders of magnitude (Fig. 2C), we found that
the uptake and fraction contained in early endosomes at early time
points were identical within error (Fig. 4G and H).
Ourﬁrst aimwas to conﬁrm that PEGylation ofMVL5-based CL–DNA
complexes yields sterically-stabilized NPs (Fig. 2). One interesting
feature in the DLS data is that contrary to CL–DNA complexes formed
with monovalent lipids [63,65,66], MVL5-based complexes are not
electrostatically stabilized by overcharging at high ρwhere they formed
micron-sized aggregates for all ρ N 2. This weak colloidal stability
suggests that steric stabilization through surface functionalization is
essential for the use of MVL5 complexes in vivo, where serum and
plasma are high ionic strength buffers (≈150 mM 1:1 NaCl), which
screen electrostatic repulsion. The addition of 10 mol% PEG2K-lipid or
RGD–PEG2K-lipid (where the PEG polymer is in the brush regime
[67]) induces the formation of sub-200 nm, sterically stabilized
nanoparticles which retain colloidal stability for up to 24 h after forma-
tion (Fig. 2B). Taken together with the live cell imaging results, DLS data
shows that PEGylation at 10 mol% screens the attractive van der Waals
force between NPs, but our live cell imaging shows that the attractive
electrostatic interaction between High-σM NPs and the anionic plasma
membrane is not fully screened at full polymer coverage (Fig. 3).
PEGylation has been previously reported to give rise to a steric-
based repulsive force between NPs and cells [52,68], so as PEG2K-lipid
mol% increases, both adhesion to the plasma membrane and fusion
with the endosomal membrane upon NP uptake become energetically
unfavorable, resulting in low TE [22,23,52]. One strategy to recover the
lost adhesion to the plasma membrane is covalent attachment of a
ligand to the distal end of the PEG2K-lipid, allowing NPs to speciﬁcally
bind to cells via a ligand–receptor interaction. Although the TE of non-
PEGylated MVL5/DOPC complexes is remarkably high, the addition of
5 and 10mol% PEG2K-lipid signiﬁcantly reduces TE (Fig. 2C). Previously
it was found that uptake of Low-σM NPs was dramatically enhanced by
addition of RGD ligand, implying integrin receptor mediated uptake
[52]. Here we ﬁnd a similar result where RGD further enhances uptake
of High-σM NPs (Fig. 3). Although RGD-tagged CL–DNA NPs can under-
go internalization in the absence of electrostatic-mediated adhesion to
the plasma membrane [52], endosomal escape requires sufﬁcient
electrostatic attraction between the anionic endosomal membrane
and cationic NP. This steric-induced inefﬁcient endosomal escape
explains why RGD-tagged NPs cannot transfect as efﬁciently as CL–
DNA complexes lacking PEGylation. In fact previous work has shown
that the endosomal escape of non-PEGylated CL–DNA complexes is
strongly dependent on σM [47], where high σM promotes electrostati-
cally-mediated fusion of the endosomal membrane and outer bilayer
of the CL–DNA complex, leading to endosomal escape. Our PEGylated
NPs are formed at high-σM but the steric repulsion of the RGD–PEG2K
motifs present on the surface of the NP inhibit endosomal escape by
giving rise to a polymer brush-induced repulsive steric force between
the endosomal membrane and NP. More evidence for weak endosomal
escape of PEGylated NPs with andwithout RGD-tagging can be found in
the live cell imaging data; our NPs lack the required machinery to
directly interact with motor proteins, implying that the observed
perinuclear accumulation of RGD-tagged NPs is a result of active
trafﬁcking of intra-endosomal NPs (Fig. 3). Finally, recent literature
has shown that targeting vectors with high internalization can still
show low TE due to weak endosomal escape [52].
Our next aim was to measure the propensity of NPs to escape
endosomes, where we used Rab5–GFP to allow endogenous labeling
of early endosomes [69]. Rab5 is involved in both clathrin-mediatedendocytosis and macropinocytosis [70], which are the main uptake
pathways of the adenovirus [71], a viral vector which also presents
RGD motifs on its surface (i.e. as part of the penton base of the viral
capsid [72]). Furthermore, colocalization of ﬂuorescently labeled
adenovirus particles with Rab5–GFP has been previously reported
[73]. While previous studies [74–76] have shown colocalization of
synthetic nucleic acid vectors and Rab5–GFP labeled endosomes,
our quantitative colocalization imaging of RGD-tagged NPs and Rab5–
GFP and comparisons to hydrolysis-deﬁcient mutant Rab5–Q79L
provides direct visual evidence that nanoparticles do not escape early
endosomes. Interestingly, despite an extensive incubation protocol,
only a small but signiﬁcant fraction of both Low and High-σM NPs
were found to colocalize with wildtype EEs. The High- and Low-σM
NPs used in our Rab5 studies differed in TE by nearly two orders of
magnitude while showing a relatively small difference in uptake and
colocalization with Rab5 endosomes.
Rab5-EEs have been previously shown to have a half life of 10–
15 min [36], implying that at 30 min post internalization NPs should
be further along the endocytic pathway. Although this line of evidence
(the short lifetime of EEs) should suggest that no NP-EE colocalization
should occur at later time points (60 min), Fig. 4H shows statistically
signiﬁcant colocalization of NPs with EEs at 60 min. Although our
incubation protocol was designed to synchronize internalization of
NPs, the increase in total uptake from 30 to 60 min in combination
with NP-EE colocalization at 60 min suggests that, once bound to the
plasma membrane, NPs cannot all simultaneously internalize. This
results in individual endocytic events occurring over a range of times
after activation of endocytosis upon warming the cells from 4 °C to
37 °C. The live cell images in Fig. 3 support this conclusion as they
show plasma membrane bound NPs at up to 4 h of incubation. Regard-
ing NPs lacking EE colocalization, we see an increase from 30 to 60 min
(GFP–Rab5(−) in Fig. 4G and H). We interpret this as RGD-tagged NPs
internalizing throughout the warm incubation, brieﬂy colocalizing
with Rab5 EEs and accumulating in later stage endocytic vesicles lacking
Rab5. In fact, recent literature [78] has shown that cationic lipid–NANPs
undergo slower internalization kinetics relative to particles with similar
size and ligands,which is in agreementwith ourmodel that at any given
early time point, a fraction of NPs are surface bound, in EEs or further
along the endocytic pathway. In summary, our wildtype Rab5 results
show that (1) once bound to the plasmamembrane there is a broad dis-
tribution of time constants for NPs to undergo internalization, (2) upon
internalization NPs pass through EEs on the scale of 30 min and accu-
mulate in later endocytic stages and (3) initial internalization and EE
colocalization do not depend on σM for RGD-tagged NPs.
Cell imaging with the mutant Rab5–Q79L has allowed us to unam-
biguously determine whether the NPs observed not to be colocalized
with EEs have escaped early endosomes into the cytoplasm, internal-
ized through a Rab5-independent mechanism, or progressed further
along the endocytic pathway. Rab5–Q79L slows maturation of early
endosomes due to very slow GTP hydrolysis activity, causing early
endosomes to continuously fuse and grow into GEEs with internal NPs
which are spatially resolvable. Nearly all ﬂuorescent NPs are found to
directly colocalize with or within GFP–Rab5–Q79L labeled GEEs
(Fig. 5). The high level of colocalization of NPs with GEEs rules out the
possibility of RGD-tagged NPs using non-Rab5 dependent pathways or
efﬁciently escaping EEs.More importantly, theRab5–Q79Ldata strongly
suggests that the relatively low amounts of colocalization observed
in wildtype Rab5–GFP is a result of the short half life of wildtype
early endosomes because increasing the lifetime of the early endosome
(i.e. with Rab5–Q79L which inhibits EE maturation) increases the
colocalization of NPs with mutant Rab5. With wildtype Rab5, a large
fraction of intracellular NPs do not colocalize with early endosomes,
but taken together with the observation of that all particles colocalize
with mutant Rab5–Q79L we conclude that the fraction of NPs which
escape endosomes do so during the later stages of endocytosis. Our
model is in agreement with recent work using EM to directly measure
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endosomal escape only occurs after NPs have resided within cells
for longer than 1.5 h [77]. Furthermore, our conclusion is also in agree-
ment with another recent literature report [78] which showed that
polyplexes and conventional lipoplexes (i.e. lacking PEG-lipid) that
internalize via clathrin-mediated endocytosis show low transfection
efﬁciency unless they are rerouted (via protein kinase A inhibition) to
another late stage endosome that lacks the familiar components of the
wildtype late endosome pathway. These authors, in agreement with
our study, concluded through indirect evidence that escape from early
endosomes is unlikely. There has also been a recent report in the litera-
ture that did directly visualize release of nucleic acid into the cytoplasm
at short timepoints (5min)which is in stark contrast to our resultswith
Rab5–Q79L where we see no evidence of escape even after 1 h of incu-
bation [79]. Twomajor differences between this report and our ﬁndings
lie in the vector and the cargo. First, our vector contains PEG-lipidwhich
has been previously shown to inhibit endosomal escape [52] as opposed
to conventional lipoplexes which are more efﬁcient carriers of nucleic
acid and could be escaping from early endosomes. Second, the early re-
lease of cargo was observed for small (20 bp) oligonucleotides via a hy-
pothesized pore forming mechanism. Our NPs carry plasmid which we
speculatewould not be able to escape endosomes via pores as efﬁciently
as small oligonucleotides.
Interestingly, the mutant and wildtype Rab5 data both show that
early endosome colocalization is not indicative of high or low TE. NPs
used in the Rab studies differed in TE by nearly two orders of magnitude
but show similar uptake, similar wildtype Rab5 colocalization and ﬁnally
similar mutant Rab5-colocalization at early time points. In summary, the
combination of wildtype andmutant Rab5 data provides direct evidence
that (1) RGD-tagged CL–DNA NPs use a Rab5-dependent pathway for
cellular uptake, (2) colocalization of PEGylated NPs, or lack thereof,
with Rab5–GFP does not depend on σM and is not indicative of high or
low TE and (3) the major bottlenecks to high TE for RGD-tagged CL–
DNA NPs are downstream of uptake and early endosomes.
Fig. 6 contains a schematic which summarizes our ﬁndings. The
observed pathways of RGD-tagged CL–DNA NPs are shown with solid
black arrows. NPs adhere to the plasmamembranewhere they undergoFig. 6. Schematic showing known and possible pathways of RGD-tagged CL–DNA NPs. Legend:
early endosome, RE: recycling endosome, LE: late endosome, MVB: multivesicular body, Lyso: l
undergo endocytosis via CCV or MPs. In the case of wildtype Rab5, NPs initially colocalize with
radative. From these later stages, a fraction of NPs escape from the endosomal pathway as evid
scales (≈1 h) an accumulation of CL–DNA NPs is found in early endosomes and no other pathw
endosomes: (1) NPs were found to not escape GEEs and (2) colocalization with EEs is not depe
escape is strongly dependent on membrane charge density.endocytosis through either macropinocytosis or clathrin-mediated en-
docytosis. Upon internalization, NPs are trafﬁcked in macropinosomes
or clathrin coated vesicles (which contain Rab5) to early endosomes.
From the early endosome, in the case of wildtype Rab5, we highlight
possible pathways of RGD-tagged CL–DNA NPs (blue, dashed arrows),
which include but are not limited to recycling endosomes or late
endosomes/multivesicular bodies. From these later endocytic stages
we know that a fraction of our particles escape the endosomal pathway
due to moderate to high levels of gene expression in our luciferase
assay. In the case of Rab5–Q79L, NPs (whether RGD-tagged or not) are
trafﬁcked to large, swollen GEEs where the vast majority remain even
up to 1 h post incubation. Finally, our observation that NPs do not
escape from GEEs at early time points provides strong evidence that
NPs cannot escape from short-lived wildtype EEs (red symbol, Fig. 6).
One possible explanation for our observation that NPs do not escape
GEEs is that the formation of recycling endosomes through ﬁssion of
early endosomes may be a crucial step for endosomal escape. It has
been previously shown that Rab5–Q79L signiﬁcantly reduces (by up
to 60%) recycling, suggesting that the growth of GEEs is due to both in-
creased fusion between EEs as well as reduced ﬁssion (i.e. formation of
recycling endosomes) [36]. However, previous work strongly suggests
that ﬁssion is not the dominantmeans of endosomal escape. First, a pre-
vious report has shown that using a PEG-lipid capable of cleavage at
low-pH leads to improved transfection efﬁciency due to improved
endosomal escape, suggesting that endosomal escape of PEGylated
NPs occurs at low pH endocytic stages which are downstream of early
endosomes [23]. Second, recent work has shown that the membrane
charge density mediates endosomal escape which strongly suggests
that escape occurs through a fusion or pore forming process. If escape
could occur through ﬁssion events we would not expect endosomal es-
cape to strongly depend on membrane charge density, which has been
previously reported [52].
5. Conclusion
PEGylation of MVL5-based CL–DNA complexes promotes the forma-
tion of sterically-stabilized nanoparticles while RGD-tagging of thePM: plasma membrane, MP: macropinosome, CCV: clathrin-coated vesicle, (G) EE: (giant)
ysosome. In both cases (wildtype or mutant Rab5) NPs bind to the plasmamembrane and
Rab5–GFP labeled vesicles and then proceed to two possible pathways, recycling or deg-
enced by measured gene expression. In the case of mutant Rab5–Q79L–GFP, at short time
ays are explored. Two distinct observations suggest that NPs do not escapewildtype early
ndent on membrane charge density, but gene expression (TE) which requires endosomal
1317R.N. Majzoub et al. / Biochimica et Biophysica Acta 1848 (2015) 1308–1318PEGylated nanoparticles improves cellular uptake and TE. Previous
work shows that the uptake of PEGylated NPs lacking RGD-tagging
strongly depends on membrane charge density [52]. Comparing our
results with those found in the literature for NPs containing univalent
cationic lipids, we note that MVL5-based NPs show improved cellular
uptake and TE when compared to NPs based on the monovalent lipid
DOTAP, consistent with the hypothesis that high membrane charge
density improves endosomal escape [52]. To further elucidate early
events in the endocytic pathway of RGD-tagged NPs we used Rab5–
GFP for endogenous labeling of early endosomes. We ﬁnd that only a
minority of intracellular NPs colocalize with Rab5–GFP at early time
points (t b 1 h). A brief survey of the literature [74–76,80–82] shows
that low levels of colocalization of synthetic vectors and Rab5-GFP
endosomes are frequently observed. We conclude that this observation
is a result of the inherent short life time of wildtype EE. Low levels of
colocalization with wildtype Rab5–GFP could imply efﬁcient escape
from the early endosome or an alternative internalization mechanism,
but our data using mutant Rab5–Q79L shows a signiﬁcant fraction of
intracellular NPs colocalizing with relatively long-lived giant
endosomes (resulting from self-fusion of early endosomes) suggesting
that escape from early endosomes is a rare event. This hypothesis is
further substantiated by the observation that although ﬂuorescence
microscopy shows that total uptake and colocalization of NPs with
early endosomes do not depend on σM, transfection efﬁciency
(a measure of exogenous gene expression), which requires endosomal
escape, strongly depends on σM implying that PEGylated NPs do not
escape from EEs. Future studies using other GTPase-deﬁcient Rab
mutants will allow for a better understanding of lipid–NA intracellular
pathways as well as optimization of vectors for improved efﬁciency.
Finally, development of NPs has been hampered by the lack of a robust
imaging platform to directly visualize the dynamics and motion of NPs
trapped in endosomes. Thus, Rab5–Q79L could allow for optical assess-
ment of early endosomal membrane penetrating peptides of different
NPs with the goal of designing membrane-penetrating NPs that escape
early endosomes.
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